First Trust Advisors’s Regenxbio RGNX Stock Holding History

First Trust Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-84,305	Closed	-$1.59M	–	2432
2023 Q1	$1.59M	Sell	84,305 -14,541	-15%	-$322K	﹤0.01%	1792
2022 Q4	$2.24M	Buy	+98,846	New	+$2.23M	﹤0.01%	1648
2021 Q4	–	Sell	-43,067	Closed	-$1.8M	–	2582
2021 Q3	$1.8M	Buy	43,067 +25,908	+151%	+$932K	﹤0.01%	1807
2021 Q2	$667K	Sell	17,159 -63,648	-79%	-$2.28M	﹤0.01%	2177
2021 Q1	$2.76M	Buy	+80,807	New	+$3.45M	﹤0.01%	1598
2019 Q3	–	Sell	-55,504	Closed	-$2.85M	–	2463
2019 Q2	$2.85M	Sell	55,504 -1,060	-2%	-$52.9K	0.01%	1368
2019 Q1	$3.24M	Sell	56,564 -7,330	-11%	-$363K	0.01%	1287
2018 Q4	$2.68M	Buy	+63,894	New	+$3.75M	0.01%	1302

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

SGL

Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

First Trust Advisors's RGNX Position: Q2 2023 in Review

First Trust Advisors sold out of Regenxbio (RGNX) in Q2 2023, closing a stake of 84,305 shares — an estimated $1.59M sold.

First Trust Advisors first reported a position in RGNX in Q4 2018 and held it in 8 quarters. The position peaked at $3.24M in Q1 2019. 166 funds tracked by Wall St. Rank hold RGNX as of Q2 2023.

First Trust Advisors reported no remaining Regenxbio position as of Q2 2023 after selling out during the quarter.
First Trust Advisors sold 84,305 Regenxbio shares in Q2 2023, an estimated $1.59M.
First Trust Advisors first reported a position in Regenxbio in Q4 2018 and held it in 8 quarters.
First Trust Advisors's Regenxbio position peaked at $3.24M in Q1 2019.
166 funds tracked by Wall St. Rank held Regenxbio as of Q2 2023.

Based on First Trust Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.